Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
Journal of Medicinal Chemistry
|
April 1, 1979
Drug-induced modifications of the immune response. 1. Substituted 1-phenylisoquinolines
V St Georgiev, R P Carlson, R G Van Inwegen, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
May 1, 1970
Indomethacin inhibits the local Shwartzman reaction
C G Van Arman, R P Carlson, W R Brown, et al.
International Journal of Immunopharmacology
|
November 1, 1993
Kidney dysfunction in the arthritic rat
J F Dijoseph, T L Walter, D A Hartman, et al.
Journal of Immunopharmacology
|
January 1, 1986
Immunomodulating activity of Wy-41,770 (5H-dibenzo[A,D]cyclohepten-5-ylidene) acetic acid
R P Carlson, L J Datko, L O'Neill-Davis, et al.
Journal of Cellular Biochemistry
|
June 1, 1989
Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents
L A Marshall, J Y Chang, W Calhoun, et al.
Agents and Actions
|
June 1, 1984
The absence of antibodies to type II collagen in established adjuvant arthritis in rats
F DeLustro, R P Carlson, L J Datko, et al.
American Journal of Veterinary Research
|
April 1, 1973
Inflammatory response in dogs given intraarticular injection of Mycobacterium butyricum-mineral oil adjuvant
R P Carlson, G E Dagle, C G Van Arman, et al.
Journal of Immunopharmacology
|
January 1, 1981
Immunomodulation of delayed hypersensitivity to methylated bovine serum albumin (MBSA) in mice using subliminal and normal sensitization procedures
A J Lewis, J Parker, J DiLuigi, et al.
Agents and Actions
|
May 1, 1992
Interaction studies of tilomisole, aspirin, and naproxen in acute and chronic inflammation with assessment of gastrointestinal irritancy in the rat
W Calhoun, S C Gilman, L J Datko, et al.
Agents and Actions
|
June 1, 1984
The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects
R P Carlson, L J Datko, J Chang, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
Journal of Medicinal Chemistry
|
April 1, 1979
Drug-induced modifications of the immune response. 1. Substituted 1-phenylisoquinolines
V St Georgiev, R P Carlson, R G Van Inwegen, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
May 1, 1970
Indomethacin inhibits the local Shwartzman reaction
C G Van Arman, R P Carlson, W R Brown, et al.
International Journal of Immunopharmacology
|
November 1, 1993
Kidney dysfunction in the arthritic rat
J F Dijoseph, T L Walter, D A Hartman, et al.
Journal of Immunopharmacology
|
January 1, 1986
Immunomodulating activity of Wy-41,770 (5H-dibenzo[A,D]cyclohepten-5-ylidene) acetic acid
R P Carlson, L J Datko, L O'Neill-Davis, et al.
Journal of Cellular Biochemistry
|
June 1, 1989
Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents
L A Marshall, J Y Chang, W Calhoun, et al.
Agents and Actions
|
June 1, 1984
The absence of antibodies to type II collagen in established adjuvant arthritis in rats
F DeLustro, R P Carlson, L J Datko, et al.
American Journal of Veterinary Research
|
April 1, 1973
Inflammatory response in dogs given intraarticular injection of Mycobacterium butyricum-mineral oil adjuvant
R P Carlson, G E Dagle, C G Van Arman, et al.
Journal of Immunopharmacology
|
January 1, 1981
Immunomodulation of delayed hypersensitivity to methylated bovine serum albumin (MBSA) in mice using subliminal and normal sensitization procedures
A J Lewis, J Parker, J DiLuigi, et al.
Agents and Actions
|
May 1, 1992
Interaction studies of tilomisole, aspirin, and naproxen in acute and chronic inflammation with assessment of gastrointestinal irritancy in the rat
W Calhoun, S C Gilman, L J Datko, et al.
Agents and Actions
|
June 1, 1984
The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects
R P Carlson, L J Datko, J Chang, et al.
Page
of 7